NEKTAR THERAPEUTICS 4
4 · NEKTAR THERAPEUTICS · Filed Jul 1, 2015
Insider Transaction Report
Form 4
WANG SUSAN
Director
Transactions
- Sale
Common Stock
2015-06-29$12.70/sh−15,000$190,500→ 20,000 total - Sale
Common Stock
2015-06-29$12.70/sh−15,000$190,500→ 20,000 total - Exercise/Conversion
Stock Option
2015-06-29−15,000→ 0 totalExercise: $5.15From: 2009-09-30Exp: 2016-12-01→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2015-06-29$8.81/sh+15,000$132,150→ 35,000 total - Exercise/Conversion
Common Stock
2015-06-29$5.15/sh+15,000$77,250→ 35,000 total - Exercise/Conversion
Stock Option
2015-06-29−15,000→ 0 totalExercise: $8.81From: 2008-09-19Exp: 2015-09-18→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $12.58 to $12.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.